secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0001193125-23-166018
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Mirum Pharmaceuticals announces results of 2023 annual meeting of stockholders
------------------------------------------------------------------------------

- Elected Lon Cardon, William Fairey, and Timothy Walbert as Class I directors to serve until 2026.
- Each director received overwhelming support: Cardon 30.6M for, Fairey 30.4M for, Walbert 27.5M for.
- Ratified Ernst & Young as independent auditor for FY 2023 with 34.2M votes for, 3.4K against.
- Total shares outstanding and entitled to vote: 38,030,661 as of record date April 17, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312523166018/0001193125-23-166018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312523166018/d522261d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-166018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer